Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

262.90
-2.8900-1.09%
Pre-market: 259.59-3.3100-1.26%05:28 EDT
Volume:3.31M
Turnover:868.11M
Market Cap:464.65B
PE:74.27
High:265.00
Open:264.60
Low:260.31
Close:265.79
52wk High:267.47
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:0.70
T/O Rate:0.19%
Dividend:6.83
Dividend Rate:2.60%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-78.29
PE(LYR):111.40

Loading ...

AbbVie Price Target Raised to $303.00/Share from $298.00 by Piper Sandler

Dow Jones
·
Aug 21

AbbVie price target raised to $303 from $298 at Piper Sandler

TIPRANKS
·
Aug 20

Piper Sandler Adjusts Price Target on AbbVie to $303 From $298, Maintains Overweight Rating

MT Newswires Live
·
Aug 20

U.S. Research Roundup-Amgen, Analog Devices, Moderna

Reuters
·
Aug 20

Gubra H1 FY26 Operating Loss Widens to DKK 122.9 Million; Revenue Drops 95% to DKK 126.3 Million

Reuters
·
Aug 20

Movement Alert|AbbVie Rises 3.04% in Regular Trading, Multiple Banks Raise Price Targets Amid Pipeline Catalysts

Market Focus
·
Aug 20

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

AbbVie EVP, Chief Business and Strategy Officer Nicholas Donoghoe Disposes of 32,710 Common Shares Worth $8.18 Million

Reuters
·
Aug 19

AbbVie Raises $9 Billion Debt to Fund Acquisition

TIPRANKS
·
Aug 19

AbbVie Closes USD 10B Multi-Tranche Senior Notes Offering to Fund Apogee Deal

Reuters
·
Aug 19

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 19

AbbVie Inc Stock (ABBV) Closed Up by 3.48% on Aug 18: Key Drivers Unveiled

TradingKey
·
Aug 19

Movement Alert|AbbVie Rises 3.03% in Regular Trading, Multiple Banks Raise Price Targets Amid Pipeline Catalyst

Market Focus
·
Aug 19

AbbVie Sets Q3 2026 Distribution at R$ 0.38 Per Unit, Payable Aug. 20

Reuters
·
Aug 18

Basilea Publishes Investor Presentation on Anti-Infectives Strategy and Pipeline Progress

Reuters
·
Aug 18

AbbVie is Maintained at Overweight by Wells Fargo

Dow Jones
·
Aug 17

Abbvie, Inc. : Wells Fargo Raises Target Price to $300 from $295

THOMSON REUTERS
·
Aug 17

Wells Fargo Adjusts Price Target on AbbVie to $300 From $295, Keeps Overweight Rating

MT Newswires Live
·
Aug 17

U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies

Reuters
·
Aug 17

AbbVie Steps Deeper Into Alzheimer’s: What the ABBV-1758 Trial Means for Investors

TIPRANKS
·
Aug 15